HK1203157A1 - Sustained delivery of molecules using peptide surfactants and uses thereof - Google Patents

Sustained delivery of molecules using peptide surfactants and uses thereof

Info

Publication number
HK1203157A1
HK1203157A1 HK15103754.3A HK15103754A HK1203157A1 HK 1203157 A1 HK1203157 A1 HK 1203157A1 HK 15103754 A HK15103754 A HK 15103754A HK 1203157 A1 HK1203157 A1 HK 1203157A1
Authority
HK
Hong Kong
Prior art keywords
molecules
sustained delivery
peptide surfactants
surfactants
peptide
Prior art date
Application number
HK15103754.3A
Other languages
English (en)
Chinese (zh)
Inventor
Sotirios Koutsopoulos
Shuguang Zhang
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of HK1203157A1 publication Critical patent/HK1203157A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15103754.3A 2012-05-31 2015-04-17 Sustained delivery of molecules using peptide surfactants and uses thereof HK1203157A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261653782P 2012-05-31 2012-05-31
PCT/US2013/043572 WO2013181511A1 (en) 2012-05-31 2013-05-31 Sustained delivery of molecules using peptide surfactants and uses thereof

Publications (1)

Publication Number Publication Date
HK1203157A1 true HK1203157A1 (en) 2015-10-23

Family

ID=49673920

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103754.3A HK1203157A1 (en) 2012-05-31 2015-04-17 Sustained delivery of molecules using peptide surfactants and uses thereof

Country Status (7)

Country Link
US (1) US20150147384A1 (ja)
EP (1) EP2854778A4 (ja)
JP (2) JP2015519374A (ja)
CA (1) CA2874003A1 (ja)
HK (1) HK1203157A1 (ja)
SG (1) SG11201407696WA (ja)
WO (1) WO2013181511A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105228592A (zh) 2013-03-14 2016-01-06 麻省理工学院 用于长时间持续释放人类抗体的多层可注射自组装肽脚手架水凝胶
CN106832000B (zh) * 2017-01-17 2021-06-22 国家纳米科学中心 一种可在肿瘤细胞溶酶体内发生形貌转换的多肽脂质体
ES2956776T3 (es) * 2017-11-09 2023-12-27 Purmx Therapeutics Inc Composición farmacéutica que comprende miARN-3140 para su uso en el tratamiento del cáncer
CN111712230B (zh) * 2017-12-15 2024-04-26 立美基股份有限公司 表面活性剂肽纳米结构及在药物递送中的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006043A1 (en) * 2001-07-10 2003-01-23 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
JP3959453B2 (ja) * 2002-03-14 2007-08-15 沖電気工業株式会社 翻訳仲介システム及び翻訳仲介サーバ
US8187621B2 (en) * 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
US20090069547A1 (en) * 2007-05-01 2009-03-12 Massachusetts Institute Of Technology Stabilization of mammalian membrane proteins by short surfactant peptides
WO2008136820A1 (en) * 2007-05-01 2008-11-13 Massachusetts Institute Of Technology Stabilization of mammalian membrane proteins by short surfactant peptides
US9714941B2 (en) * 2007-07-31 2017-07-25 Massachusetts Institute Of Technology Bio-sensing nanodevice
WO2010014903A1 (en) * 2008-07-31 2010-02-04 Massachusetts Institute Of Technology Multiplexed olfactory receptor-based microsurface plasmon polariton detector
SG193822A1 (en) * 2008-08-27 2013-10-30 3 D Matrix Ltd Transfection agent
JP2010222338A (ja) * 2009-02-27 2010-10-07 Three D Matrix:Kk 核酸移送担体
JP2011012042A (ja) * 2009-07-03 2011-01-20 Three D Matrix:Kk 核酸徐放担体
JP2011126855A (ja) * 2009-12-15 2011-06-30 Three D Matrix:Kk タンパク質の凝集抑制剤

Also Published As

Publication number Publication date
JP2015519374A (ja) 2015-07-09
US20150147384A1 (en) 2015-05-28
EP2854778A4 (en) 2016-03-30
JP2018052935A (ja) 2018-04-05
WO2013181511A1 (en) 2013-12-05
EP2854778A1 (en) 2015-04-08
SG11201407696WA (en) 2014-12-30
CA2874003A1 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
IL260045B (en) Polypeptide structures and their uses
EP2870170A4 (en) NOVEL PEPTIDES AND THEIR USE
HK1197184A1 (en) Selective delivery molecules and methods of use
EP2788370A4 (en) MODIFIED MINI-HEPCIDINE PEPTIDES AND METHODS OF USE
EP2721061A4 (en) STABILIZED VARIANT MAML PEPTIDES AND USES THEREOF
IL279676A (en) Recombinant proteins and therapeutic uses
EP2782589A4 (en) ANTIMICROBIAL PEPTIDES AND METHOD FOR THEIR USE
HK1201454A1 (en) Therapeutic agents and uses thereof
SG11201500111VA (en) Peptides and uses thereof
EP2738255A4 (en) PEPTIDE FROM ERAP1 AND ITS USE
HK1204772A1 (en) Aromatic-cationic peptides and uses of same
HK1203161A1 (en) Peptides and methods of using same
SG11201501646PA (en) Peptides and their uses
ZA201401210B (en) Peptide nanoparticles and uses thereof
EP2793921A4 (en) PEPTIDES DERIVED FROM SAPOSIN A AND USES THEREOF
PL2667880T3 (pl) Oligopeptydy metaloproteinaz i ich zastosowanie terapeutyczne
HK1203157A1 (en) Sustained delivery of molecules using peptide surfactants and uses thereof
EP2825548A4 (en) MODIFIED KISSPEPTIN PEPTIDES AND USES THEREOF
EP2740740A4 (en) PEPTIDE DERIVED FROM A LIGAND EDAR AND USES THEREOF
EP2907870A4 (en) REPROGRAMMING PEPTIDE AND USE THEREOF
EP2762149A4 (en) PEPTIDE DERIVED FROM ERYTHROPOIETIN AND USE THEREOF
HK1206977A1 (en) Aromatic-cationic peptides and uses of same
EP2918600A4 (en) NEW PEPTIDE AND ITS USE
EP2873676A4 (en) PEPTIDE WITH LOW MOLECULAR WEIGHT AND USE THEREOF